Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Technogenetics Signs Five Year Distribution Agreement With Menarini

For an automated test system to diagnose autoimmune diseases

Immunodiagnostic Systems (IDS) has reported that Italy-based Technogenetics has signed a five year distribution agreement with A Menarini Diagnostics (Menarini) covering Europe for an automated test system, the Zenit RA, together with a panel of 21 tests for the diagnosis of autoimmune diseases. The Zenit RA is an OEM version of the IDS-iSYS system.

IDS had signed an OEM manufacturing and supply agreement with Technogenetics, a subsidiary of Bouty, the clinical diagnostics company, on 5 October 2009. As part of this agreement IDS will supply IDS-iSYS systems and consumables to Technogenetics on an OEM basis.

The systems, branded as the Zenit RA and consumables will be sold by Menarini as ‘closed system’ instruments throughout the whole of Europe and countries of the former Soviet Union such as Russia and Ukraine.

Lorenzo Castellini, president of Bouty Group, said: “We expect that over the five years the distribution agreement with A. Menarini Diagnostics will generate approximately €12m in revenues from sales of diagnostic kits manufactured by Technogenetics with additional income from sales of instruments and ancillary reagents supplied by IDS.”

Roger Duggan, CEO of IDS, said: “We’re very pleased to see that our collaboration with Technogenetics is about to bear fruit and the deal signed between Technogenetics and Menarini significantly expands the route to market for Technogenetics’ autoimmune products. This can only enhance future sales of IDS-manufactured instruments and ancillary reagents across Europe, a great ‘upside’ to our agreement with Technogenetics.”